![]() |
|
|
AB Malmberg and TL Yaksh
Department of Anesthesiology, University of California, San Diego, La Jolla.
Subcutaneous injection of formalin into the dorsal surface of the hindpaw evoked a two-phased flinching (phase 1:0-9 min; phase 2: 10-60 min) of the injected paw. Intrathecal administration of the nonsteroidal anti-inflammatory drugs (NSAID) produced minimal effects upon phase 1, but showed a significant, though submaximal, dose- dependent suppression of the phase 2 response. Ordering of i.t. potency was (ID50 in nmol): indomethacin (1.9) > or = flurbiprofen (2.1) > ketorolac (5.2) > or = zomepirac (5.9) > S(+)ibuprofen (16) > or = ibuprofen(racemic) (19) > acetylsalicylic acid (27) > acetaminophen (250) > R(-)ibuprofen (> 270) = 0. Intraperitoneal administration also produced a dose-dependent inhibition of phase 2, but only at doses which were 100 to 1000 times higher than those required to produce similar effects after i.t. injection. Intrathecal and i.p. dose- response curves showed similar distinct plateaus of maximum achievable inhibition (intrinsic activity) of the phase 2 behavior, ranging from 20 to 50% of the control response. Varying the time of drug injection reveals that injection 9 min after formalin yielded effects the same as those observed when the agent was given 2 min before formalin. Pretreatment at longer intervals indicated that the duration of the antinociceptive effect was between 3 to 6 hr after the i.t. injection. The i.t. injection of the highest doses of the several NSAID were without significant effect upon the 52.5 degrees C hot plate test. These studies indicate that NSAID have a powerful effect upon spinal nociceptive processing evoked by the s.c. injection of formalin.
This article has been cited by other articles:
![]() |
E. Kumpulainen, H. Kokki, M. Laisalmi, M. Heikkinen, J. Savolainen, J. Rautio, and M. Lehtonen How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children? J. Clin. Pharmacol., April 1, 2008; 48(4): 495 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kokki, E. Kumpulainen, M. Lehtonen, M. Laisalmi, M. Heikkinen, J. Savolainen, and J. Rautio Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children Pediatrics, October 1, 2007; 120(4): e1002 - e1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McNamara, J. Mandel-Brehm, D. M. Bautista, J. Siemens, K. L. Deranian, M. Zhao, N. J. Hayward, J. A. Chong, D. Julius, M. M. Moran, et al. TRPA1 mediates formalin-induced pain PNAS, August 14, 2007; 104(33): 13525 - 13530. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet, L. Ouchchane, C. Deval, J.-P. Courade, M. Ferrara, A. Eschalier, et al. Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System Mol. Pharmacol., February 1, 2007; 71(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mannila, E. Kumpulainen, M. Lehtonen, M. Heikkinen, M. Laisalmi, T. Salo, J. Rautio, J. Savolainen, and H. Kokki Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration J. Clin. Pharmacol., January 1, 2007; 47(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Guevara-Lopez, A. Covarrubias-Gomez, H. Gutierrez-Acar, J. A. Aldrete, F. J. Lopez-Munoz, and B. Martinez-Benitez Chronic Subarachnoid Administration of 1-(4chlorobenzoyl)-5methoxy-2methyl-1H-indole-3 Acetic Acid (Indomethacin): An Evaluation of Its Neurotoxic Effects in an Animal Model. Anesth. Analg., July 1, 2006; 103(1): 99 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy, X. Guo, J. Kelschenbach, Y. Liu, and H. H. Loh In Vivo Activation of a Mutant {micro}-Opioid Receptor by Naltrexone Produces a Potent Analgesic Effect But No Tolerance: Role of {micro}-Receptor Activation and {delta}-Receptor Blockade in Morphine Tolerance J. Neurosci., March 23, 2005; 25(12): 3229 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Dionne, D. Haynes, J. S. Brahim, J. S. Rowan, and P.-H. Guivarc'h Analgesic Effect of Sustained-Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model J. Clin. Pharmacol., December 1, 2004; 44(12): 1418 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Docquier, P. Lavand'homme, V. Boulanger, V. Collet, and M. De Kock Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia Br. J. Anaesth., September 1, 2004; 93(3): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yaksh, K. A. Horais, N. Tozier, M. Rathbun, P. Richter, S. Rossi, M. Grafe, C. Tong, C. Meschter, J. M. Cline, et al. Intrathecal Ketorolac in Dogs and Rats Toxicol. Sci., August 1, 2004; 80(2): 322 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, P. Lebrun, F. Camu, and M. Zizi Intrathecal Catheterization and Solvents Interfere with Cortical Somatosensory Evoked Potentials Used in Assessing Nociception in Awake Rats Anesth. Analg., July 1, 2004; 99(1): 159 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Hua, C. S. Hayes, A. Hofer, B. Fitzsimmons, K. Kilk, U. Langel, T. Bartfai, and T. L. Yaksh Galanin Acts at GalR1 Receptors in Spinal Antinociception: Synergy with Morphine and AP-5 J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 574 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Korkmaz, F. Maltepe, S. Erbayraktar, O. Yilmaz, M. Guray, M. S. Canda, A. Gunerli, and N. Gokmen Antinociceptive and Neurotoxicologic Screening of Chronic Intrathecal Administration of Ketorolac Tromethamine in the Rat Anesth. Analg., January 1, 2004; 98(1): 148 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonabello, M. R. Galmozzi, R. Canaparo, G. C. Isaia, L. Serpe, E. Muntoni, and G. P. Zara Dexibuprofen (S(+)-Isomer Ibuprofen) Reduces Gastric Damage and Improves Analgesic and Antiinflammatory Effects in Rodents Anesth. Analg., August 1, 2003; 97(2): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hayashida, T. Takeuchi, H. Shimizu, K. Ando, and E. Harada Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R306 - R312. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aldrete Epidural Injections of Indomethacin for Postlaminectomy Syndrome: A Preliminary Report Anesth. Analg., February 1, 2003; 96(2): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. C. Sabino, J. R. Ghilardi, J. L. M. Jongen, C. P. Keyser, N. M. Luger, D. B. Mach, C. M. Peters, S. D. Rogers, M. J. Schwei, C. de Felipe, et al. Simultaneous Reduction in Cancer Pain, Bone Destruction, and Tumor Growth by Selective Inhibition of Cyclooxygenase-2 Cancer Res., December 15, 2002; 62(24): 7343 - 7349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Freshwater, C. I. Svensson, A. B. Malmberg, and N. A. Calcutt Elevated Spinal Cyclooxygenase and Prostaglandin Release During Hyperalgesia in Diabetic Rats Diabetes, July 1, 2002; 51(7): 2249 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamamoto and N. Nozaki-Taguchi The Role of Cyclooxygenase-1 and -2 in the Rat Formalin Test Anesth. Analg., April 1, 2002; 94(4): 962 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Bars, M. Gozariu, and S. W. Cadden Animal Models of Nociception Pharmacol. Rev., December 1, 2001; 53(4): 597 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kelly, M. Ahmad, and S. J. Brull Preemptive analgesia I: physiological pathways and pharmacological modalities : [L'analgesie preventive I : mecanismes physiologiques et modalites pharmacologiques] Can J Anesth, November 1, 2001; 48(10): 1000 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Milne, S. R. Hall, M. E. Sullivan, and C. Loomis The Release of Spinal Prostaglandin E2 and the Effect of Nitric Oxide Synthetase Inhibition During Strychnine-Induced Allodynia Anesth. Analg., September 1, 2001; 93(3): 728 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yaksh, D. M. Dirig, C. M. Conway, C. Svensson, Z. D. Luo, and P. C. Isakson The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 J. Neurosci., August 15, 2001; 21(16): 5847 - 5853. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Kidd and L. A. Urban Mechanisms of inflammatory pain Br. J. Anaesth., July 1, 2001; 87(1): 3 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Yaksh, G. Ozaki, D. McCumber, M. Rathbun, C. Svensson, S. Malkmus, and M. C. Yaksh An automated flinch detecting system for use in the formalin nociceptive bioassay J Appl Physiol, June 1, 2001; 90(6): 2386 - 2402. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Baba, T. Kohno, K. A. Moore, and C. J. Woolf Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2 J. Neurosci., March 1, 2001; 21(5): 1750 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
D McCarthy Prostaglandins, COX-2, and sensory perception Gut, December 1, 2000; 47(90004): iv66 - 68. [Full Text] [PDF] |
||||
![]() |
C. -S. Wong, M. -M. Hsu, R. Chou, Y. -Y. Chou, and C. -S. Tung Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats Br. J. Anaesth., November 1, 2000; 85(5): 747 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Dunbar, I. G. Karamov, and H. Buerkle The Effect of Spinal Ibuprofen on Opioid Withdrawal in the Rat Anesth. Analg., August 1, 2000; 91(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, and T. Yamaguchi The Systemically Administered Competitive AMPA Receptor Antagonist, YM872, has Analgesic Effects on Thermal or Formalin-Induced Pain in Rats Anesth. Analg., December 1, 1999; 89(6): 1534 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, and T. Yamaguchi The Spinal Antinociceptive Effects of a Novel Competitive AMPA Receptor Antagonist, YM872, on Thermal or Formalin-Induced Pain in Rats Anesth. Analg., July 1, 1999; 89(1): 143 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Tighe, A. M. Webb, and G. J. Hobbs Persistently High Plasma Morphine-6-Glucuronide Levels Despite Decreased Hourly Patient-Controlled Analgesia Morphine Use After Single-Dose Diclofenac: Potential for Opioid-Related Toxicity Anesth. Analg., May 1, 1999; 88(5): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. S. Santos, O. G. Miguel, R. A. Yunes, and J. B. Calixto Antinociceptive Properties of the New Alkaloid, cis-8,10-Di-N-Propyllobelidiol Hydrochloride Dihydrate Isolated from Siphocampylus verticillatus: Evidence for the Mechanism of Action J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 417 - 426. [Abstract] [Full Text] |
||||
![]() |
M.-F. Jett, C. S. Ramesha, C. D. Brown, S. Chiu, C. Emmett, T. Voronin, T. Sun, C. O'Yang, J. C. Hunter, R. M. Eglen, et al. Characterization of the Analgesic and Anti-Inflammatory Activities of Ketorolac and Its Enantiomers in the Rat J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1288 - 1297. [Abstract] [Full Text] |
||||
![]() |
C. J. Smith, Y. Zhang, C. M. Koboldt, J. Muhammad, B. S. Zweifel, A. Shaffer, J. J. Talley, J. L. Masferrer, K. Seibert, and P. C. Isakson Pharmacological analysis of cyclooxygenase-1 in inflammation PNAS, October 27, 1998; 95(22): 13313 - 13318. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, A. Shaffer, J. Portanova, K. Seibert, and P. C. Isakson Inhibition of Cyclooxygenase-2 Rapidly Reverses Inflammatory Hyperalgesia and Prostaglandin E2 Production J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1069 - 1075. [Abstract] [Full Text] |
||||
![]() |
D. Bustamante, C. Paeile, J.-C. Willer, and D. Le Bars J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1381 - 1391. [Abstract] [Full Text] |
||||
![]() |
S. R. Chaplan, A. B. Malmberg, and T. L. Yaksh Efficacy of Spinal NMDA Receptor Antagonism in Formalin Hyperalgesia and Nerve Injury Evoked Allodynia in the Rat J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 829 - 838. [Abstract] [Full Text] |
||||
![]() |
L. A. Pini, G. Vitale, A. Ottani, and M. Sandrini Naloxone-Reversible Antinociception by Paracetamol in the Rat J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 934 - 940. [Abstract] [Full Text] |
||||